EndoChoice Holdings Inc. (NYSE:GI) shares dropped 2% during trading on Monday . The stock traded as low as $4.89 and last traded at $4.94, with a volume of 79,102 shares. The stock had previously closed at $5.04.

GI has been the subject of several research analyst reports. Bank of America Corp. cut shares of EndoChoice Holdings from a “neutral” rating to an “underperform” rating and set a $10.00 target price for the company. in a report on Thursday, March 24th. Zacks Investment Research cut shares of EndoChoice Holdings from a “hold” rating to a “sell” rating in a report on Tuesday, May 3rd.

The stock’s 50-day moving average is $4.47 and its 200 day moving average is $5.20. The company’s market capitalization is $128.49 million.

EndoChoice Holdings (NYSE:GI) last announced its quarterly earnings results on Wednesday, May 4th. The company reported ($0.68) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.55) by $0.13. The firm had revenue of $18.46 million for the quarter, compared to the consensus estimate of $18.34 million. During the same period last year, the business posted ($1.00) earnings per share. The business’s revenue for the quarter was up 10.2% on a year-over-year basis. On average, equities analysts expect that EndoChoice Holdings Inc. will post ($2.01) earnings per share for the current year.

An institutional investor recently raised its position in EndoChoice Holdings stock. Kornitzer Capital Management Inc. KS boosted its stake in shares of EndoChoice Holdings Inc. (NYSE:GI) by 17.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 169,900 shares of the company’s stock after buying an additional 25,400 shares during the period. Kornitzer Capital Management Inc. KS owned about 0.69% of EndoChoice Holdings worth $1,419,000 at the end of the most recent reporting period.

Endochoice Holdings, Inc, formerly ECPM Holdings, LLC, is a medical device company. The Company is focused on designing and commercializing a platform of products for gastrointestinal (GI) caregivers. It offers a range of products and services that span single-use devices and infection control products, pathology and imaging systems.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.